トルコのトップ肺癌に対する免疫療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
23
トルコ
レビュー
14000+
実際の患者より
トップ各国の肺癌に対する免疫療法価格を比較
国をタップしてトップ医師と価格を表示
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示：
55名の方が先月見積もりをリクエストしました
エダ・タンリクル医師はトルコを代表する腫瘍内科医の一人であり、アナドル医療センターにて肺癌に対する免疫療法を専門としています。
141名の方が先月見積もりをリクエストしました
ブルント・カラゲズ博士は、トルコのトップ医療腫瘍学者であり、肉腫、リンパ腫、膵臓、肺がんの専門家であり、乳がん外科の医師で、20年以上の経験を持ちます。彼の主なサブスペシャリティは、腫瘍生物学、腫瘍免疫学、がん免疫療法、標的療法です。
がん研究で40を超える出版物を執筆しています。
ヨーロッパ頭頸部協会
32名の方が先月見積もりをリクエストしました
ハジェテペ大学およびMDアンダーソンがんセンターで研鑽を積んだ腫瘍学専門医。
Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.
Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.
Education and Specialization
Work Experience
Expertise
44名の方が先月見積もりをリクエストしました
シナン・カラアスラン医師は、アナドル医療センターにおける肺癌の免疫療法を専門とし、10年以上にわたる腫瘍学の専門的な診療経験を有する。
イェシム・ユルドゥルム教授は、がん免疫療法および分子標的療法を専門とし、80を超える国際的な学術論文・著書を有しています。
Şeref Kömürcü教授は、ECFMGおよびESMO認定の医療および乳腺腫瘍学者であり、トルコを拠点に20年以上の実践経験を持っています。硬癌、乳癌、大腸癌、肺癌の治療を専門としています。
癌管理に関する110を超える論文を書いています。
プロフェッサー ネジデット・ユシュケントは、アンカラ大学医学部を卒業しました。彼はアンカラGATA医学校で内科医学のレジデンシー研修を修了しました。彼はアメリカのテキサス州ダラスで医療用腫瘍学および血液学の臨床フェローシップ研修を行いました。トルコで最初の移植を実施した骨髄移植チームに参加しました。異なる時期に、彼はロンドンのウェストミンスター病院 チャリングクロス、ハマースミス、ロイヤル フリー、ユニバーシティ カレッジ 病院で長期間の客員講師を務め、スイスのバーゼル カントン病院でも講義しました。欧州医学腫瘍学会（ESMO）によって主催された試験に合格し、彼はヨーロッパ医学腫瘍学証明書を取得しました。トルコ医学腫瘍学会の7人の創設会員の1人として、プロフェッサー ユシュケントはトルコ腫瘍学グループ（TOG）の創設者でもありました。
学歴
アンカラ大学医学部, アンカラ 1971
GATA 医学校, アンカラ 1979
ワドレー分子医学研究所, グランビル・モートンがん病院, 医療用腫瘍学および血液学のサブスペシャリティ, 1982
GATA 医学校, 医療用腫瘍学クリニック, アンカラ 1984
GATA 医学校, 医療用腫瘍学クリニック, アンカラ 1989
GATA, 医療用腫瘍学および血液学クリニック, イスタンブール 2001
専門分野
Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.
この医師は、乳がん、肺がん、消化器系がんの治療を専門とする腫瘍学者です。現在、医師はIstinye Liv University Hospitalで診療を行っています。<\/p>
多くの著名な機関でのキャリアを持ち、医師はMalatya State Hospitalで内科専門医として、Ankara Oncology Clinicで医師として、Erzurum Regional Training and Research Hospitalの腫瘍学部門のメンバーとして勤務してきました。<\/p>
医師はSelcuk Universityの医学部を卒業し、2016年に准教授の称号を取得しました。<\/p>
Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.
Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
23名の医師のうち20名をご覧いただきました
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 21年の経験 | 肺癌に対する免疫療法 | トルコの腫瘍内科において第3位にランク付けされており、国際臨床試験においてリーダーシップを発揮しています。主要な研究病院における元診療科長。 | トルコ | から $215 | |
| #2 | 20年の経験 | 肺癌免疫療法 | MDアンダーソンがんセンターにて研鑽を積む——腫瘍学の分野において世界的に高い評価を受ける施設である。肺癌をはじめとする複数の癌腫を専門とする。 | トルコ | から $100 | |
| #3 | 29年の経験 | 肺癌免疫療法 | 肺癌免疫療法を専門とし、トルコ肺癌学会に所属。イスタンブール大学の著名な腫瘍学プログラムで研鑽を積む。 | トルコ | から $215 | |
| #4 | 22年の経験 | 肺癌免疫療法 | 最先端の免疫療法の専門家であり、マウント・バーノン・キャンサー・センターにて専門的なトレーニングを受けた。複数の腫瘍学書籍の著者であり、ESMOの会員でもある。 | トルコ | から $215 |
Lung cancer doctors in Türkiye often hold prestigious international certifications to validate their expertise. These specialists frequently achieve European Society for Medical Oncology (ESMO) certification. Many also hold American Educational Commission for Foreign Medical Graduates (ECFMG) credentials. This global recognition ensures they follow the latest immunotherapy protocols.
Bookimed Expert Insight: Data shows a high concentration of internationally trained talent at Anadolu Medical Center. Dr. Yesim Yildirim and Dr. Necdet Uskent both completed fellowships in Israel and the USA. This clinic also maintains a strategic affiliation with Johns Hopkins Medicine. Patients can access consultations with these experts starting from $215.
Patient Consensus: Patients note that doctors at university-affiliated centers offer very clear explanations in English. They emphasize the importance of seeing specialists who regularly manage immune-related side effects. Many felt more confident after learning their doctor trained at top-tier global cancer centers.
Turkish hospitals such as Anadolu Medical Center host globally recognized lung cancer specialists holding ESMO certifications and international fellowships. These experts utilize Johns Hopkins Medicine protocols and advanced biomarker testing for immunotherapy. Leading oncologists are active members of the International Association for the Study of Lung Cancer.
Bookimed Expert Insight: Data shows a concentration of lung cancer expertise at Anadolu Medical Center, which holds the Organisation of European Cancer Institutes certificate. While many centers offer general oncology, specialists here like Dr. Bulent Karagoz and Dr. Sinan Karaaslan offer focused consultations for approximately $215. This specific academic focus on tumor immunology distinguishes them from general practitioners.
Patient Consensus: Patients note that verifying an oncologist's specific experience with lung cancer is vital. Many highlight the importance of tumor boards where surgery and oncology teams collaborate on treatment plans. They often emphasize that academic reputation and biomarker testing speed matter more than hospital marketing.
Turkish medical oncologists determine immunotherapy candidacy by evaluating PD-L1 expression levels and molecular tumor profiles. They follow international ESMO guidelines to match therapies with specific biomarkers. Experts confirm that a patients physical fitness and the absence of certain genetic mutations are vital for successful treatment.
Bookimed Expert Insight: Data shows that top Turkish oncologists often have extensive international training specifically in immune-related toxicities. For example, Dr. Yesim Yildirim at Anadolu Medical Center completed specialized immunotherapy training at Mount Vernon Cancer Center in London. This international exposure allows them to manage complex cases that involve combining immunotherapy with chemotherapy or targeted treatments effectively.
Patient Consensus: Patients note that molecular testing is the essential first step before any treatment begins. They often mention that doctors are very cautious about autoimmune history or organ health. Many found it helpful when a tumor board reviewed their specific case for better results.
Turkish oncologists prescribe globally recognized immune checkpoint inhibitors for lung cancer following ESMO and NCCN guidelines. These include Pembrolizumab, Nivolumab, Atezolizumab, and Durvalumab. Specialists at accredited centers determine the best drug through advanced tumor profiling and PD-L1 biomarker testing.
Bookimed Expert Insight: Analysis shows that top Turkish oncologists, such as Dr. Yesim Yildirim and Dr. Nail Paksoy, hold ESMO board certifications. This helps patients access the same clinical protocols used in Western Europe. Many of these specialists have completed fellowships at institutions like MD Anderson or Oxford University. This international training often allows patients to join global clinical trials while receiving treatment in Istanbul or Antalya.
Patient Consensus: Patients note that doctors take the time to explain how specific biomarkers like PD-L1 affect their drug choice. They often feel more confident after receiving clear results from the hospital's advanced genetic profiling labs. Many mention they appreciate having a dedicated coordinator handle their medication schedules and hospital stays.
Lung cancer doctors in Turkey communicate effectively in English due to extensive international training and university programs taught in English. Leading oncologists hold certifications from the European Society for Medical Oncology (ESMO) and have practiced at major centers in the US and UK.
Bookimed Expert Insight: Data shows a high concentration of internationally trained oncologists at Anadolu Medical Center. For example, several professors there hold dual certifications and have completed fellowships in London or Israel. Patients can book consultations with these experts starting from $215 to verify communication skills before traveling.
Patient Consensus: Patients note that medical English is generally strong in major private centers, especially regarding treatment steps. They suggest sending pathology reports in advance to discuss specific immunotherapy details via email first. Many found that having a dedicated bilingual coordinator helped clarify complex medication schedules and discharge plans.
Turkish oncologists coordinate lung cancer follow-up care through structured digital consultations and detailed medical handoffs. Specialists provide survivorship plans and laboratory thresholds to local physicians. This approach maintains treatment continuity. Online oncology consultations at leading clinics like Anadolu Medical Center start around $215.
Bookimed Expert Insight: Turkish oncology leaders often possess specific international certifications that facilitate global collaboration. For example, Dr. Yesim Yildirim at Anadolu Medical Center is European Society of Medical Oncology (ESMO) certified. This shared standard helps Turkish doctors align follow-up protocols with international best practices. Patients benefit from experts who have trained at centers like Mount Vernon in the UK.
Patient Consensus: Patients note they leave Turkey with a detailed summary packet in English. They feel more prepared when they have a one-page summary for their local doctor. Many highlight that staying in touch via WhatsApp helps during the first few weeks back home.